Agenus Inc (AGEN) stock
AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.29−0.44 (-6.54%)
Close on Nov 16, 2026Market cap $283.18MP/E –Yield –
Agenus EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Agenus's EV/EBITDA was 7.4× on Nov 10, 2026.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 10, 2026 | 7.4× | – |
See a number that looks wrong?